Home

Brett R. Hagen, Chief Accounting Officer: Kalaris Therapeutics KLRS Sell · Filed 23/01/23

Trade details

Type
Insider sale
Amount
$7,909.56
Shares · price
1,557 sh · $5.08 a share
Held after
74,342 sh
Trade date
23/01/19
Filed
23/01/23
Days to filing
4 days

Sold 2.1% of holdings

Share of holding sold
2.1%

Kalaris Therapeutics trades, last 26 weeks

What else happened in Kalaris Therapeutics around then

Filed or reported within 30 days of the trade day · 22/12/20~23/02/18

Brett R. Hagen's recent trades

  • Brett R. Hagen

    SellKalaris Therapeutics

    $12.9K

    Filed 03/23

  • Brett R. Hagen

    Planned saleKalaris Therapeutics

    $12.9K

    Filed 03/20

  • Brett R. Hagen

    SellKalaris Therapeutics

    $8,136

    Filed 25/03/27

  • Brett R. Hagen

    SellKalaris Therapeutics

    $968

    Filed 25/02/24

  • Brett R. Hagen

    Planned saleKalaris Therapeutics

    $967

    Filed 25/02/24